Unity Biotechnology, Inc. ( UBX) - Key Metrics
Stock symbol UBX is outdated, potentially delisted? Maybe it is available on other exchange?
UBX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q1 | ? | -$0.43 | -$0.38 | -$0.38 |
| 2024Q4 | ? | -$0.50 | -$0.35 | -$0.35 |
| 2024Q3 | ? | -$0.38 | -$0.31 | -$0.31 |
| 2024Q2 | ? | -$0.31 | -$0.27 | -$0.27 |
| 2024Q1 | ? | -$0.34 | -$0.31 | -$0.31 |
UBX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q1 | ? | -0.60 |
| 2024Q4 | ? | -0.49 |
| 2024Q3 | ? | -0.96 |
| 2024Q2 | ? | -1.06 |
| 2024Q1 | ? | -1.20 |
UBX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q1 | -36.23% | ? |
| 2024Q4 | -35.94% | ? |
| 2024Q3 | -20.97% | ? |
| 2024Q2 | -20.50% | ? |
| 2024Q1 | -18.60% | ? |
UBX
Price: $0.20
52 week price:
Earnings Per Share: -1.63 USD
P/E Ratio: -0.18
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 71934
Market Capitalization: 5.0 million